AI Summary

A newly identified strain of Candida auris, now called Candidozyma auris, is resistant to all major antifungal drugs, prompting concern among health‑care experts. The pathogen, first described in 2009, has spread to more than 60 countries across six continents and is linked to hospital outbreaks and invasive infections. Reported mortality rates for affected patients range from 30 % to 50 % in some cases. This drug resistance underscores the growing challenge of managing the fungus in health‑care settings.

AI summaries can be wrong sometimes—always verify important details using the source article.